Cargando…

Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides

Herpes Simplex virus Type-2 (HSV-2) increases the risk of HIV-1 acquisition, yet the mechanism for this viral pathogen to regulate the susceptibility of the cervicovaginal mucosa to HIV-1 is virtually unknown. Using ex vivo human ectocervical tissue models, we report greater levels of HIV-1 reverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rollenhagen, C, Lathrop, M J, Macura, S L, Doncel, G F, Asin, S N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137741/ https://www.ncbi.nlm.nih.gov/pubmed/24496317 http://dx.doi.org/10.1038/mi.2014.3

Ejemplares similares

Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues
por: Macura, Sherrill L., et al.
Publicado: (2016)

Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues
por: Rollenhage, Christiane, et al.
Publicado: (2015)

Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease
por: Suazo, Paula A., et al.
Publicado: (2014)

Microbicides & their implications in HIV prevention
por: Karim, Salim S. Abdool, et al.
Publicado: (2010)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?
por: Klasse, Per Johan, et al.
Publicado: (2006)

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Seminal exosomes and HIV‐1 transmission
por: Ouattara, Louise A., et al.
Publicado: (2018)

Sexual network drivers of HIV and herpes simplex virus type 2 transmission
por: Omori, Ryosuke, et al.
Publicado: (2017)

Lignosulfonic Acid Exhibits Broadly Anti-HIV-1 Activity – Potential as a Microbicide Candidate for the Prevention of HIV-1 Sexual Transmission
por: Qiu, Min, et al.
Publicado: (2012)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

Can a Topical Microbicide Prevent Rectal HIV Transmission?
por: Hladik, Florian, et al.
Publicado: (2008)

Topical microbicides to prevent the transmission of HIV: formulation gaps and challenges
por: Turpin, Jim A.
Publicado: (2011)

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants
por: Fletcher, Patricia S, et al.
Publicado: (2006)

Hyperthermia Stimulates HIV-1 Replication
por: Roesch, Ferdinand, et al.
Publicado: (2012)

Tumor-like herpes simplex infection in an HIV patient()()
por: Nieto-Benito, Lula María, et al.
Publicado: (2021)

Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women
por: Anderson, Sharon M., et al.
Publicado: (2020)

Nanotechnology Applications to HIV Vaccines and Microbicides
por: Boyapalle, Sandhya, et al.
Publicado: (2012)

Microbicides and HIV: A Review and an update
por: Naswa, Smriti, et al.
Publicado: (2012)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides
por: Neurath, A Robert, et al.
Publicado: (2006)

Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1
por: Buckheit, Karen W., et al.
Publicado: (2012)

Development of HIV-1 Rectal-Specific Microbicides and Colonic Tissue Evaluation
por: Dezzutti, Charlene S., et al.
Publicado: (2014)

Microbicide Containing Ellagic Acid Can Inhibit HIV-1 Infection
por: Nittayananta, Wipawee, et al.
Publicado: (2022)

Atypical Perianal Herpes Simplex Infection in HIV-Positive Patients
por: Simonsen, Marcelo, et al.
Publicado: (2008)

Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania
por: Issakwisa, Habakkuk Mwakyula, et al.
Publicado: (2020)

P17-06. Development of a replication-defective Herpes Simplex virus 1 recombinant expressing HIV-1 clade A envelope protein
por: Sen, J, et al.
Publicado: (2009)

UBE1a Suppresses Herpes Simplex Virus-1 Replication
por: Ikeda, Marina, et al.
Publicado: (2020)

Inhibition of HIV-1 Infection in Ex Vivo Cervical Tissue Model of Human Vagina by Palmitic Acid; Implications for a Microbicide Development
por: Lin, Xudong, et al.
Publicado: (2011)

Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses
por: Eid, Sahar G, et al.
Publicado: (2015)

In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
por: Rohan, Lisa C., et al.
Publicado: (2010)

Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
por: Pirrone, Vanessa, et al.
Publicado: (2012)

Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection
por: Brouwers, Joachim, et al.
Publicado: (2008)

Herpes Simplex Virus Type 2, Genital Ulcers and HIV-1 Disease Progression in Postpartum Women
por: Roxby, Alison C., et al.
Publicado: (2011)

Microbicides: a new hope for HIV prevention
por: Nutan,, et al.
Publicado: (2011)

Algal Lectins as Potential HIV Microbicide Candidates
por: Huskens, Dana, et al.
Publicado: (2012)

Microbicides for the Treatment of Sexually Transmitted HIV Infections
por: Singh, Onkar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h2hil9jmtno59nfri0o36ib118